Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
出版年份 2016 全文链接
标题
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
作者
关键词
-
出版物
LIVER INTERNATIONAL
Volume 36, Issue 12, Pages 1755-1764
出版商
Wiley
发表日期
2016-09-16
DOI
10.1111/liv.13253
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
- (2016) Joseph Ahn et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
- (2016) George Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
- (2015) W. Ray Kim et al. CANCER
- Causes of death in people with chronic HBV infection: A population-based cohort study
- (2015) Celine Montuclard et al. JOURNAL OF HEPATOLOGY
- Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Perspectives and control of hepatitis B virus infection in Taiwan
- (2015) Chih-Lin Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Hepatitis B Virus Genotypes and Variants
- (2015) C.-L. Lin et al. Cold Spring Harbor Perspectives in Medicine
- The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy
- (2014) C. S. Coffin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis
- (2014) Soon Sun Kim et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study
- (2014) Chun-Ying Wu et al. GASTROENTEROLOGY
- Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
- (2014) Pauline Arends et al. GUT
- Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
- (2014) Ju-Yeon Cho et al. GUT
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B
- (2014) Y.-C. Hsu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Improving clinical outcomes of chronic hepatitis B virus infection
- (2014) Tung-Hung Su et al. Expert Review of Gastroenterology & Hepatology
- Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population
- (2013) Stuart C. Gordon et al. Clinical Gastroenterology and Hepatology
- Impact of Therapy on the Long-Term Outcome of Chronic Hepatitis B
- (2013) Yun-Fan Liaw Clinics in Liver Disease
- Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
- (2013) Grace Lai-Hung Wong et al. HEPATOLOGY
- Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants
- (2013) S.-C. Yang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
- (2012) Roeland Zoutendijk et al. GUT
- Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy
- (2012) Ching-Lung Lai et al. HEPATOLOGY
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study
- (2011) G. V. Papatheodoridis et al. GUT
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
- (2010) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program
- (2009) Guadalupe Garcia-Tsao et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
- (2007) Giovanna Fattovich et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation